Drawing for ONCOTIME

USPTO serial 98271002

ONCOTIME

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CASTRO, GIANCARLO
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ONCOTIME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher D. Olszyk, Jr.

Christopher D. Olszyk, Jr. FOX ROTHSCHILD LLP212 Carnegie Center, Suite 400Princeton, NJ 08540United States

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic reagents, other than for medical or veterinary purposes; diagnostic reagents for scientific or research use; reagents for scientific or medical research useACTIVE—
005Research use only chemical reagents for clinical medical or veterinary purposes; diagnostic reagents for medicinal research useACTIVE—
010Research use only biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for evaluating appropriate immunotherapy cancer treatments; Research use only cancer screening tests and devices, namely, medical devices for evaluating immunotherapy cancer treatment options; Research use only cancer screening tests and devices, namely, medical devices for matching cancer diagnosis with cancer treatments; Research use only medical diagnostic apparatus for testing a patient's response to various immunotherapy cancer treatment options in order to help determine the most effective course of treatment for that patientACTIVE—
042Providing reagent sample testing and diagnostic services for others in the field of cancer testing research, tumor testing research, and screening for the purpose of evaluating patient immunotherapy cancer treatment optionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 14, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 14, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 12, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 12, 2026EX3GSOU EXTENSION 3 GRANTED—
Feb 11, 2026EXT3SOU EXTENSION 3 FILED—
Feb 11, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 14, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 13, 2025EX2GSOU EXTENSION 2 GRANTED—
Aug 13, 2025EXT2SOU EXTENSION 2 FILED—
Aug 13, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 13, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 13, 2025EX1GSOU EXTENSION 1 GRANTED—
Feb 13, 2025EXT1SOU EXTENSION 1 FILED—
Feb 12, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 13, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 18, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 18, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 29, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 9, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 9, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 8, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 8, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 1, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 2024DOCKASSIGNED TO EXAMINER—
Dec 20, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 18, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance